glp-1 anti-obesity GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach GLP-1R Agonists for Weight Loss

They may also prescribe other GLP-1s, such as Zepbound, Wegovy, and Saxendra

An FDA spokesperson told Scientific American that the agency monitors imported drugs and active ingredients to ensure they meet the same federal requirements as those manufactured domestically

Weight loss varies by medication, dose, adherence, side effects, nutrition, activity, sleep, and medical history

[DOI] [PMC free article] [PubMed] [Google Scholar] [139].Marre M, Shaw J, Brandle M, Bebakar WM, Kamaruddin NA, Strand J, Zdravkovic M, Le Thi TD, Colagiuri S, L.-S.s

Furthermore, we could not directly control for disease severity and management quality of medical conditions, including diabetes duration, glycemic control, body mass index, and lipid profile